At Guy’s and St Thomas’ Pharmaceuticals, we improve patient care by rapidly turning frontline clinical insights into practical treatment solutions. Our aim is to ensure that every patient receives the treatment they need.
Expertise from world-leading hospitals
Our 5 hospitals – Evelina London Children’s, Guy’s, Harefield, Royal Brompton and St Thomas’ – offer expertise across a broad range of specialisms.
This uniquely places us to develop treatments in diverse areas, including heart and lung care, dentistry, dermatology, critical care, ophthalmology, and children’s health.
Clinically-led solutions
Our MHRA-regulated facilities are embedded in a live clinical environment, enabling us to turn clinical challenges into patient-driven solutions quickly and effectively – even for rare diseases.
As we are specialists in clinically essential, low-volume medicines, we can develop bespoke formulations to meet complex or critical requirements.
In addition, we manufacture and supply a range of high‑quality bulk intermediate products to pharmaceutical compounding partners, to prepare final, ready‑to‑administer dosage formulations tailored to patient needs.
Manufacturing capabilities
With our technical expertise, we provide a distinct and comprehensive range of manufacturing capabilities across both sterile and non‑sterile pharmaceutical products, delivering to the highest standard. View our list of formulations below.
Solid oral dosage formulations:
- Capsules.
- Tablets.
Liquid and semi‑solid formulations:
- Creams.
- Gels.
- Ointments.
- Oral solutions.
- Oral suspensions.
- Topical liquids.
Solid formulations:
- Bulk intermediates.
Liquid formulations:
- Eye drops.
- Small volume injectables.
Advancing clinical research
Through collaboration with leading research organisations, we are a trusted clinical research partner, supporting Investigational Medicinal Product (IMP) manufacture for small scale and global clinical trials.
Our services cover investigator-led and sponsored studies, including advice, dossiers, medicine production, matched placebos and labelling for early, through to late phase studies (Phases I-IV).
Reinvesting into the NHS
We’re proud to be part of the NHS, with all profits reinvested into our NHS Trust.
As one of the largest public healthcare providers in the UK, this ensures that we can continue advancing care for the benefit of all patients.
Pharmaceuticals contact form
Please fill in our contact form below and we will get back to you as soon as we can.